UB Paderborn / Katalog / Suche / in CDI

Interaction of Varenicline with Classic Antiseizure Medications in the Mouse Maximal Electroshock-Induced Seizure Model

International journal of molecular sciences, 2023-01, Vol.24 (3), p.2616

2023

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of LC-MS/MS Method for Determination of Cytisine in Human Serum and Saliva

International journal of molecular sciences, 2023-10, Vol.24 (20), p.15364

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Various Chromatographic Systems for Analysis of Cytisine in Human Serum, Saliva and Pharmaceutical Formulation by HPLC with Diode Array, Fluorescence or Mass Spectrometry Detection

Molecules (Basel, Switzerland), 2019-07, Vol.24 (14), p.2580

2019

Link zum Volltext

Verfügbarkeit prüfen

Fatal Carney Complex in Siblings Due to De Novo Large Gene Deletion

The journal of clinical endocrinology and metabolism, 2017-11, Vol.102 (11), p.3924-3927

2017

Link zum Volltext

Verfügbarkeit prüfen

Determination of Cytisine and N-Methylcytisine from Selected Plant Extracts by High-Performance Liquid Chromatography and Comparison of Their Cytotoxic Activity

Toxins, 2020-08, Vol.12 (9), p.557

2020

Link zum Volltext

Verfügbarkeit prüfen

Stepwise Glucoheptoamidation of Poly(Amidoamine) Dendrimer G3 to Tune Physicochemical Properties of the Potential Drug Carrier: In Vitro Tests for Cytisine Conjugates

Pharmaceutics, 2020-05, Vol.12 (5), p.473

2020

Link zum Volltext

Verfügbarkeit prüfen

Hyperglycemia Potentiates Prothrombotic Effect of Aldosterone in a Rat Arterial Thrombosis Model

Cells (Basel, Switzerland), 2021-02, Vol.10 (2), p.471

2021

Link zum Volltext

Verfügbarkeit prüfen

Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation

Addiction (Abingdon, England), 2019-11, Vol.114 (11), p.1951-1969

2019

Link zum Volltext

Verfügbarkeit prüfen

Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation

Expert opinion on investigational drugs, 2008-10, Vol.17 (10), p.1473-1485

Tutka, Piotr

2008

Link zum Volltext

Verfügbarkeit prüfen

Cytisine for smoking cessation: Current evidence

Pharmacological reports, 2013-05, Vol.65 (Suppl 1), p.5-6

Tutka, Piotr

2013

Link zum Volltext

Verfügbarkeit prüfen

Heat capacity of cytisine – the drug for smoking cessation

European journal of pharmaceutical sciences, 2023-04, Vol.183, p.106397-106397, Article 106397

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-07, Vol.326 (1), p.56

2021

Link zum Volltext

Verfügbarkeit prüfen

Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy

Pharmacological reports, 2006-11, Vol.58 (6), p.777

2006

Link zum Volltext

Verfügbarkeit prüfen

The cytisine-enriched poly(3-hydroxybutyrate) fibers for sustained-release dosage form

International journal of biological macromolecules, 2023-08, Vol.245, p.125544-125544, Article 125544

2023

Link zum Volltext

Verfügbarkeit prüfen

Modification of NO-cGMP Pathway Differentially Affects Diazepam- and Flunitrazepam-Induced Spatial and Recognition Memory Impairments in Rodents

Neurotoxicity research, 2020-04, Vol.37 (4), p.1036-1046

2020

Link zum Volltext

Verfügbarkeit prüfen

Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity

Clinical pharmacology and therapeutics, 2004-07, Vol.76 (1), p.64-72

2004

Link zum Volltext

Verfügbarkeit prüfen

Effects of androsterone on the protective action of various antiepileptic drugs against maximal electroshock-induced seizures in mice

Psychoneuroendocrinology, 2019-03, Vol.101, p.27-34

2019

Link zum Volltext

Verfügbarkeit prüfen

The effectiveness, safety and cost‐effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non‐inferiority trial

Addiction (Abingdon, England), 2019-05, Vol.114 (5), p.923-933

2019

Link zum Volltext

Verfügbarkeit prüfen

Getting cytisine licensed for use world-wide: a call to action

Addiction (Abingdon, England), 2016-11, Vol.111 (11), p.1895-1898

2016

Link zum Volltext

Verfügbarkeit prüfen

Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model

Journal of Neural Transmission, 2014-07, Vol.121 (7), p.707-715

2014

Link zum Volltext

Verfügbarkeit prüfen

Cytisine inhibits the protective activity of various classical and novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice

Psychopharmacology, 2017, Vol.234 (2), p.281-291

2017

Link zum Volltext

Verfügbarkeit prüfen

Stimulation of 5‐HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats

British journal of pharmacology, 1996-11, Vol.119 (5), p.813-818

1996

Link zum Volltext

Verfügbarkeit prüfen

Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice

Pharmacology, biochemistry and behavior, 2011-04, Vol.98 (2), p.261-267

2011

Link zum Volltext

Verfügbarkeit prüfen

Arvanil, olvanil, AM 1172 and LY 2183240 (various cannabinoid CB1 receptor agonists) increase the threshold for maximal electroshock-induced seizures in mice

Pharmacological reports, 2018-02, Vol.70 (1), p.106-109

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Interaction of Varenicline with Classic Antiseizure Medications in the Mouse Maximal Electroshock-Induced Seizure Model

Development and Validation of LC-MS/MS Method for Determination of Cytisine in Human Serum and Saliva

Comparison of Various Chromatographic Systems for Analysis of Cytisine in Human Serum, Saliva and Pharmaceutical Formulation by HPLC with Diode Array, Fluorescence or Mass Spectrometry Detection

Fatal Carney Complex in Siblings Due to De Novo Large Gene Deletion

Determination of Cytisine and N-Methylcytisine from Selected Plant Extracts by High-Performance Liquid Chromatography and Comparison of Their Cytotoxic Activity

Stepwise Glucoheptoamidation of Poly(Amidoamine) Dendrimer G3 to Tune Physicochemical Properties of the Potential Drug Carrier: In Vitro Tests for Cytisine Conjugates

Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial

Hyperglycemia Potentiates Prothrombotic Effect of Aldosterone in a Rat Arterial Thrombosis Model

Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation

Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation

Cytisine for smoking cessation: Current evidence

Heat capacity of cytisine – the drug for smoking cessation

Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial

Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy

The cytisine-enriched poly(3-hydroxybutyrate) fibers for sustained-release dosage form

Modification of NO-cGMP Pathway Differentially Affects Diazepam- and Flunitrazepam-Induced Spatial and Recognition Memory Impairments in Rodents

Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity

Effects of androsterone on the protective action of various antiepileptic drugs against maximal electroshock-induced seizures in mice

The effectiveness, safety and cost‐effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non‐inferiority trial

Getting cytisine licensed for use world-wide: a call to action

Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model

Cytisine inhibits the protective activity of various classical and novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice

Stimulation of 5‐HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats

Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice

Arvanil, olvanil, AM 1172 and LY 2183240 (various cannabinoid CB1 receptor agonists) increase the threshold for maximal electroshock-induced seizures in mice

Suchergebnisse filtern